3 insider filings
Paul B Manning, insider filing for CADL
Show all 3
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
Paul B Manning
CADL
Candel Therapeutics, Inc. SEC filings
Every EDGAR filing for Candel Therapeutics, Inc. (CADL), newest first, with AI summaries and stories.
- Ticker
- CADL
- CIK
- 1841387
- Latest filing
- Oct 2
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Filings
4Candel Therapeutics, Inc.CADLLIVE 4Candel Therapeutics, Inc.CADLLIVE Paul Peter Tak, insider filing for CADL
Paul Peter Tak, reporting
144Candel Therapeutics, Inc.CADLLIVE Paul Peter Tak, planned sale of CADL shares
Paul Peter Tak, reporting
4Candel Therapeutics, Inc.CADLLIVE 2 insider filings
Martine Zimmermann, insider filing for CADL
Show all 2
- 4Insider filing for CADL
- 3New insider at CADL
Martine Zimmermann, reporting
8-KCandel Therapeutics, Inc.CADLLIVE 8-KCandel Therapeutics, Inc.CADLLIVE 4Candel Therapeutics, Inc.CADLLIVE Seshu Tyagarajan, insider filing for CADL
Seshu Tyagarajan, reporting
144Candel Therapeutics, Inc.CADLLIVE Seshu Tyagarajan, planned sale of CADL shares
Seshu Tyagarajan, reporting
10-QCandel Therapeutics, Inc.CADLLIVE 8-KCandel Therapeutics, Inc.CADLLIVE SCHEDULE 13GCandel Therapeutics, Inc.CADLLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
4Candel Therapeutics, Inc.CADLLIVE 2 insider filings
Mark E. Sims, insider filing for CADL
Show all 2
- 4Insider filing for CADL
- 3New insider at CADL
Mark E. Sims, reporting
4Candel Therapeutics, Inc.CADLLIVE 5 insider filings
Francesca Barone, insider filing for CADL
Show all 5
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
Francesca Barone, reporting
144Candel Therapeutics, Inc.CADLLIVE 2 Form 144 notices
Seshu Tyagarajan, planned sale of CADL shares
Show all 2
- 144Planned insider sale of CADL shares
- 144Planned insider sale of CADL shares
Seshu Tyagarajan, reporting
4Candel Therapeutics, Inc.CADLLIVE 9 insider filings
Maha Radhakrishnan, insider filing for CADL
Show all 9
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
Maha Radhakrishnan, reporting
8-KCandel Therapeutics, Inc.CADLLIVE 8-KCandel Therapeutics, Inc.CADLLIVE 8-KCandel Therapeutics, Inc.CADLLIVE SCHEDULE 13GCandel Therapeutics, Inc.CADLLIVE Ownership stake disclosure by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP, filed by
10-QCandel Therapeutics, Inc.CADLLIVE 8-KCandel Therapeutics, Inc.CADLLIVE DEFA14ACandel Therapeutics, Inc.CADLLIVE ARSCandel Therapeutics, Inc.CADLLIVE DEF 14ACandel Therapeutics, Inc.CADLLIVE SCHEDULE 13G/ACandel Therapeutics, Inc.CADLLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
4Candel Therapeutics, Inc.CADLLIVE 3 insider filings
Paul B Manning, insider filing for CADL
Show all 3
- 4Insider filing for CADL
- 4Insider filing for CADL
- 4Insider filing for CADL
Paul B Manning, reporting
SCHEDULE 13D/ACandel Therapeutics, Inc.CADLLIVE Ownership stake disclosure by Paul B Manning (amended)
Paul B Manning, filed by
S-8Candel Therapeutics, Inc.CADLLIVE 10-KCandel Therapeutics, Inc.CADLLIVE 8-KCandel Therapeutics, Inc.CADLLIVE 4Candel Therapeutics, Inc.CADLLIVE Paul B Manning, insider filing for CADL
Paul B Manning, reporting